Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetic modeling

S E Strand1, P Zanzonico, T K Johnson

  • 1Department of Radiation Physics, Lund University, University Hospital, Sweden.

Medical Physics
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Technical note: The UF/MSK pediatric mesh-based computational human phantom library: applications to organ dosimetry in computed tomography.

Physics in medicine and biology·2026
Same author

The UF/MSK adult mesh-based computational human phantom library: applications to organ dosimetry in computed tomography.

Physics in medicine and biology·2025
Same author

Radioactive seed localization is a safe and effective tool for breast cancer surgery: an evaluation of over 25,000 cases.

Journal of radiological protection : official journal of the Society for Radiological Protection·2024
Same author

KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver.

EJNMMI research·2020
Same author

ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals.

Annals of the ICRP·2019
Same author

Correction to: <sup>18</sup>F-Fluciclovine (<sup>18</sup>F-FACBC) PET imaging of recurrent brain tumors.

European journal of nuclear medicine and molecular imaging·2019

Pharmacokinetic modeling is crucial for accurate radiation dosimetry with radiolabeled monoclonal antibodies (MAb). This review covers various models and their application in predicting MAb distribution for improved dosimetry calculations.

Area of Science:

  • Pharmacology
  • Radiochemistry
  • Medical Physics

Background:

  • Pharmacokinetics is critical for radiation dosimetry calculations of radiolabeled monoclonal antibodies (MAb).
  • Accurate estimation of cumulated activity in organs requires robust pharmacokinetic modeling.
  • Understanding MAb pharmacokinetics necessitates quantitative studies in humans and validation through animal models.

Purpose of the Study:

  • To summarize methodologies for pharmacokinetic modeling of radiolabeled MAb.
  • To critically review different pharmacokinetic models (empirical, analytical, compartmental).
  • To demonstrate the utility of modeling for predictive calculations in dosimetry.

Main Methods:

  • Characterization of empirical, analytical, and compartmental pharmacokinetic models.

Related Experiment Videos

  • Review of in vivo studies in humans and animals.
  • Evaluation of macroscopic and microscopic distribution of radiolabeled MAb.

    • Main Results:

    • Pharmacokinetic modeling aids in estimating cumulated activity in organs.
    • Limited human studies and animal data currently inform MAb pharmacokinetic models.
    • Extracorporeal immunoadsorption can validate pharmacokinetic models by altering MAb biokinetics.

    Conclusions:

    • Accurate dosimetry requires understanding MAb pharmacokinetics and distribution.
    • Mathematical models are essential for precise tumor dosimetry, especially with non-homogeneous uptake.
    • Modeling capabilities can predict altered pharmacokinetics for improved dosimetric calculations.